Ohmura, Hirofumi
Yamaguchi, Kyoko
Hanamura, Fumiyasu
Ito, Mamoru
Makiyama, Akitaka
Uchino, Keita
Shimokawa, Hozumi
Tamura, Shingo
Esaki, Taito
Mitsugi, Kenji
Shibata, Yoshihiro
Oda, Hisanobu
Tsuchihashi, Kenji
Ariyama, Hiroshi
Kusaba, Hitoshi
Oda, Yoshinao
Akashi, Koichi
Baba, Eishi
Article History
Received: 28 October 2019
Revised: 12 February 2020
Accepted: 6 March 2020
First Online: 23 March 2020
Ethics approval and consent to participate
: This study was approved by the Ethics Committee of Kyushu University Hospital, Kyushu Hospital, Kyushu Medical Center, Kyushu Cancer Center, Hamanomachi Hospital, Wajiro Hospital, and Saiseikai Fukuoka General Hospital, and was performed according to the guidelines for biomedical research specified in the Declaration of Helsinki. Written, informed consent was obtained from each patient participating in this study.
: The data used and analysed during this study are available from the corresponding author on reasonable request.
: H.Oh.: none to declare; K.Y.: Ono Pharmaceutical; F.H.: none to declare; M.I.: none to declare; A.M.: none to declare; K.U.: Speakers’ Bureau of Ono Pharmaceutical; S.T.: none to declare; H.S.: none to declare; T.E.: Speakers’ Bureau of Bristol-Myers Squibb Japan and Ono Pharmaceutical and Research Funding from Ono Pharmaceutical; K.M.: Speakers’ Bureau of Ono Pharmaceutical; Y.S.: none to declare; H.Od.: none to declare; K.T.: none to declare; H.A.: none to declare; H.K.: none to declare; Y.O.: none to declare; K.A.: Speakers’ Bureau of Bristol-Myers Squibb and Research Funding from Bristol-Myers Squibb and Ono Pharmaceutical; E.B.: Honoraria from Ono Pharmaceutical and Bristol-Myers Squibb.
: No funding was required in the preparation of this paper.